Supriya Singh, MD
Hospitalist · Cleveland, OHNPI 1366812109
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,971 of the $2,391 with a category attached, or 82.4%. 14 manufacturers reported payments, led by Insmed, Inc. at 30.0% of the total. Among hospitalist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 92 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$718
- AbbVie$346
- La Jolla Pharmaceutical Company$321
- Astellas Pharma US Inc$316
- Shionogi Inc$168
- Ferring Pharmaceuticals Inc.$144
- plus $379 from 8 others
What the payments were for
- Food & beverage$1,97182%
- Education$42018%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 30 | $718 |
| AbbVie | 15 | $346 |
| La Jolla Pharmaceutical Company | 12 | $321 |
| Astellas Pharma US Inc | 5 | $316 |
| Shionogi Inc | 7 | $168 |
| Ferring Pharmaceuticals Inc. | 5 | $144 |
| Melinta Therapeutics, LLC | 6 | $118 |
| Merck | 2 | $65 |
| Johnson & Johnson | 3 | $54 |
| Cumberland Pharmaceuticals, Inc. | 2 | $43 |
| Resmed Corp | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
How this compares
$2,391 in reported general payments places this provider in the 95th percentile of 813 hospitalist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErtapenemErtapenem Sodium | 19 | $13,671 |
| Vancomycin Hcl | 65 | $7,423 |
| Cefepime Hcl | 19 | $5,610 |
| Daptomycin | 22 | $5,258 |
| Meropenem | 20 | $4,604 |
| Itraconazole | 14 | $3,428 |
| Tenofovir Disoproxil Fumarate | 14 | $3,056 |
| Ampicillin Sodium | 19 | $2,782 |
| Ceftazidime | 18 | $2,476 |
| CeftriaxoneCeftriaxone Sodium | 43 | $1,852 |
| Doxycycline Hyclate | 29 | $1,397 |
| Ethambutol Hcl | 24 | $1,209 |
| Rifampin | 18 | $1,119 |
| Fluconazole | 15 | $693 |
| Ciprofloxacin Hcl | 20 | $614 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Cleveland
- Chandramohan MeenakshisundaramCleveland$54K
- Roop KawCleveland$8K
- Patrick GradyCleveland$6K
- Andre FabienCleveland$6K
- Angel DelphiaCleveland$2K
- Zachary StrumpfCleveland$2K
- Kirshan LalDayton$28K
- Geeta SrivastavaCincinnati$10K
- Danielle ClemmerColumbus$9K
- Robert RubinCincinnati$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.